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Abstract 
Measles, rubella, mumps, hepatitis B virus (HBV) and varicella zoster virus (VZV) cause infectious diseases that 
can be effectively prevented by vaccination. Vaccination of medical students is important, because they are more 
likely to become exposed and infected by these viruses. A total of 180 students, consisting of 90 women and 90 
men, were serologically screened for measles, rubella and mumps, HBV and VZV antibodies. Their sera were 
examined for Immunoglobulin G (IgG) antibody against these viruses by using ELISA IgG kits. Total antibody 
against measles, rubella, mumps, HBV and VZV were 52%, 100%, 76%, 68% and 15% respectively. There was 
no significant difference in antibodies level according to gender. 
The results of this study indicate vaccination is vital for medical student prior to hospital training. 
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Introduction 
Vaccination is a suitable method for preventing 
contagious diseases 
1
. Currently, vaccination can 
provide protection against viruses such as measles, 
rubella, mump, HBV, VZV, etc.  
Measles is a high risk and transmissible virus that 
causes significant mortality among children. Annually 
infection by measles virus accounts for 4% of mortality 
in children aged less than 4. Significantly, the 
prevalence of infection by measles virus has been 




Unlike measles, rubella cause mild infection in 
children but can cause serious disease in pregnant 
women. During the first trimester of gestation, rubella 
virus may cause intrauterine infection and afflict the 
fetus with congenital rubella syndrome (CRS), by 
passing through the placenta 
4
. Annually 200,000 new 
CRS cases are reported, mostly from developing 
countries.  
Infection by mumps virus is mild and less serious than 
rubella and may cause orchitis and meningitis 
5
. A 
nationwide vaccination program against mumps virus 
was launched in Iran during 2003 and 5 to 25 years -
old individuals were vaccinated by MR (measles and 
rubella) vaccine. 
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Despite significant decrease in symptomatic measles 
and rubella infections, some individuals are still 
vulnerable to these viruses 
3
. 
Hepatitis B virus (HBV) and varicella zoster virus 
(VZV) are two viruses that have become a global 
concern. HBV vaccination program started in 1984 in 
many countries around the world. This virus accounts 
for one million deaths yearly, with approximately 350 
million carriers. Altogether, one billion people have 
been infected with HBV infection totally.  In 1993, 
first HBV vaccination program was launched in Iran 
6
. 
Fortunately, HBV incidence has been decreased in Iran 
during the last decade. This can be due to increasing 
knowledge  and   awareness of people about possible 
risk factors 
7
. HBV has diverse routes of transmission. 
Risk factors such as needle stick, hemodialysis, blood 
transfusion, sharing needle among drug users, high risk 
sexual behavior, etc. 
8
. Every contaminated object or 
infected person by HBV can cause disease. Among the 
350 million people with chronic infections the 
mortality rate due to HBV such as end-stage cirrhosis 




Primary VZV mostly infects children and causes 
chicken pox or varicella 
9
.This virus affects many 
children aged from 2 to 5 years in temperate climate. 




Also VZV has seasonal outbreak and is prevalent in 
late winter and early spring every second year 
10, 11
. 
VZV infection have been reported to occur  in patients 
with vascular diseases during last decades and causes 
serious infections in  immunocompromised people 
12
.  




Country’s health organizations are responsible for 
eradicating these viruses.  
Infections caused by these noxious viruses are 




The personnel of most hospitals and clinical centers are 
at risk of infection with these viruses, because they are 
commonly in contact with infected patients. Also 
medical students who pass basic sciences and enter 
clinical training stage are needed to be vaccinated if 
they lack protective antibodies against these viruses. 
Therefore, the aim of the present study was to 
determine immunity against aforementioned viruses in 
medical students before attending hospital courses. 
Materials & Methods 
Blood samples were collected randomly from 180 
medical and dental students including 90 males and 90 
females, aged from 18 to 21 years. The sera were 
separated by centrifugation at 5000 rpm and stored at - 
20°C and then transferred to The Department of 
Bacteriology and Virology of Shiraz University of 
Medical Sciences, Shiraz, Iran. The sera were used to 
evaluate antibodies against measles, mumps, and 




The ELISA kits employed for antibody detection 
included measles virus IgG ELISA (IBL company), 
RUB IgG (DIAPRO company), anti-mumps virus IgG 
ELISA (EURUIMMUN company, Germany), Anti-
HBs commercial immune enzyme (anti-HB kit, Radim, 
Italy) and VZV (EURUIMMUN company, Germany). 
In all, the  manufacturer's instructions for kit were 
followed in examinations.    
The statistical analysis was done using Chi-square test 
and SPSS (Version 17) software. Thoroughly, P values 
less than 0.05 were considered statistically significant. 
Results 
The highest (100%) and the lowest (15%) level of 
protection were observed against rubella and VZV 
respectively (Fig. 1). The respective rates of other 
antibodies were 52%, 76% and 68% for measles, 
mumps and HBV. Except for anti HBV, there was no 
significant difference between males and females in the 
incidence rates of other under-investigation viruses. 
Females were more protected than males against HBV. 
Anti HBV was significantly acceptable in 66 women in 
comparison with 56 men. Throughly, the P value was 
0.05. 
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Figure 1: Explicit comparison among rate of antibodies in measles, 
rubella, mumps, HBV and VZV 
Discussion 
The present study was performed to determine the rate 
of vaccination-induced protection against measles, 
rubella, mumps, and hepatitis B viruses among medical 
and dental students. As a point, students had not been 
vaccinated against varicella zoster virus at all. Despite 
vaccination against viruses, immunity rate was not 
sufficient in any individuals, except for rubella virus 
with100% protection.  
The low protection rate of measles virus compared to 
other viruses studied is a matter of concern.  This virus 
was responsible for 777000 deaths in 2000 (1, 15) and 
opposite to its low prevalence in developed countries, 
morbidity caused by measles virus in developing 
countries is relatively high 
2, 16
. 
In 2002, the University of New South Wales launched 
an investigation on vaccination rates 
15
. The protection 
rates were 70.5%, 1.9%, 89.6%, 87.4%, 73.8% and 
67.1% for HBs, HBc, VZV, rubella, measles and 
mumps respectively.  
Another study showed that  more than 90% of the 
students reported were immune to measles, mumps, 
rubella, and hepatitis B 
16
. 
In 2003, an investigation was carried out after 
vaccination campaigns in Tehran, Iran 
17
. Surprisingly, 
even though vaccines lacked anti-mumps capacity, 
results showed high and acceptable protection against 
this virus. This event might relate to accidental 
childhood infections that have led to production of 
antibody. Unlike what we found, their results showed 
high protection rate against measles which may be due 
to decreasing antibody titers over time or even can be 
due to insufficient dosage of vaccines for optimal 
protection. 
In 2006, another research was done in Shiraz, Iran 
18
. 
They found more protection against rubella than 
measles which was consistent with our findings. 
However, they found higher rate of antibody against 
measles among 20 to 26 years-old individuals that can 
be due to long lasting immunity. 
According to the results from current study, 
unexpectedly, protection against VZV and HBV were 
15% and 68% respectively, considering that none of 
the students had been vaccinated against VZV. 
Even though there was no considerable variability in 
regard to gender, we found different prevalence 
regarding HBV among males and females. One reason 
is that 31 males and 19 females had never been 
vaccinated or because of oversight had not received a 
complete course of vaccination.  In addition, the 
difference in the abovementioned prevalence maybe 
due to the inherent resistance of males (n=56) 
compared to females (n=66) to HBV. Another study 
has indicated a higher protection against measles in 
women compared with men 
19
. 
Vaccination has been considered as an important health 
care issue according to global application of immune-
prophylaxis and chemoprophylaxis that indicates 
mandatory vaccination for all hospital staffs, especially 
students attending clinical courses 
19
. 
Furthermore, vaccination is regarded as an effective 
strategy to prevent dissemination of viruses.  The 
production of high titer protective antibody guarantees 
protection against viral infection in the community and 
is geared towards applying accurate dose of vaccine 
and observing appropriate immunization schedules 
19
. 
In conclusion it is recommended that antibody titer be 
evaluated in medical students across the country before 
attending clinical courses. 
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